Loading...
Pneumococcal carriage and disease in adults hospitalised with community-acquired pneumonia in Mongolia: prospective pneumonia surveillance program (2019-2022)
Зохиогч
Mungun, Tuya
Ulziibayar, Munkhchuluun
Nguyen, Cattram D
Batsaikhan, Purevsuren
Suuri, Bujinlkham
Luvsantseren, Dashtseren
Narangerel, Dorj
Do, Lien Anh Ha
Ong, Darren Suryawijaya
Ortika, Belinda D
Pell, Casey L
Boelsen, Laura K
Wee-Hee, Ashleigh C
Spry, Leena
Hinds, Jason
Pride, Michael W
Dunne, Eileen M
Gessner, Bradford D
Mulholland, E Kim
Satzke, Catherine
von Mollendorf, Claire
Он
2025 оны арван нэгдүгээр сар
Төрөл
journal article
Journal
Pneumonia (Nathan Qld.)
Volume
17
Issue
1
Start Page
27
ISSN
2200-6133
Хураангуй
BACKGROUND: Streptococcus pneumoniae is an important cause of pneumonia in older adults, however, serotyping and indirect impact information from low and middle-income countries is lacking. Mongolia has a childhood 13-valent pneumococcal conjugate vaccine (PCV13) program, but no adult pneumococcal vaccination program. We describe pneumococcal carriage rates, disease and serotype distribution among adults hospitalised with pneumonia, and explore changes over the COVID-19 pandemic period.
METHODS: Adults (≥ 18 years) hospitalised with clinical pneumonia were enrolled over 3 years (March 2019-February 2022) into a prospective pneumonia surveillance program. Nasopharyngeal swabs were tested to detect pneumococci using lytA qPCR and molecular serotyping by DNA microarray and metagenomics. Pneumococcal pneumonia was identified using serotype-specific urinary antigen detection and BinaxNOW® assays. Pneumococcal carriage and pneumonia prevalence were assessed over the COVID-19 period with log-binomial regression used to estimate prevalence and adjusted prevalence ratios (pre- versus early- and late-COVID-19 periods).
RESULTS: Of 3,178 pneumonia cases, S. pneumoniae was identified in 12.1% (333/2,759) of swabs and 8.6% (253/2,925) of urine samples. PCV13 serotype carriage prevalence was 3.1% (82/2,663) and non-PCV13 serotype carriage prevalence 5.7% (152/2,663). In the late-COVID-19 period, pneumococcal carriage prevalence was reduced by 66% (aPR 0.34, 95%CI 0.25-0.46) and pneumococcal pneumonia by 82% (aPR 0.18, 95%CI 0.12-0.27) compared with the pre-COVID-19 transmission period.
CONCLUSION: Despite paediatric vaccination with high coverage, we identified some residual PCV13 serotypes with predominance of non-PCV13 serotypes carried and causing disease in adults. Direct adult vaccination which targets these serotypes will potentially reduce disease in adults in Mongolia.
